| |
| |
|
| Insider
Information: |
Moore Matthew Richard |
| Relationship: |
SVP and Chief Business... |
| City: |
Westlake Village |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
145,505 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,164,040 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
145,505 |
|
|
| Total
Value |
$1,164,040 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arcutis Biotherapeutics, Inc. |
ARQT |
SVP and Chief Business... |
2024-05-02 |
145,505 |
2022-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARQT |
Arcutis Biotherapeutics, ... |
SVP and Chief Business Officer |
• – – |
2024-05-02 |
4 |
S |
$8.74 |
$40,902 |
D/D |
(4,681) |
145,505 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
SVP and Chief Business Officer |
• – – |
2024-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,166 |
150,186 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
SVP and Chief Business Officer |
• – – |
2024-03-04 |
4 |
AS |
$11.12 |
$38,568 |
D/D |
(3,468) |
146,020 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
SVP and Chief Business Officer |
• – – |
2024-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
94,898 |
149,488 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
SVP and Chief Business Officer |
• – – |
2024-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
54,590 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• – – |
2023-03-02 |
4 |
AS |
$15.82 |
$25,481 |
D/D |
(1,610) |
11,690 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,900 |
26,590 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
SVP and Chief Business Officer |
• – – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
13,300 |
13,300 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
